本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vaxcyte, Inc.

60.37
+1.602.72%
成交量:130.92萬
成交額:7,928.86萬
市值:89.83億
市盈率:-7.89
高:61.50
開:60.22
低:59.31
收:58.77
52周最高:65.00
52周最低:30.89
股本:1.49億
流通股本:1.36億
量比:0.88
換手率:0.96%
股息:- -
股息率:- -
每股收益(TTM):-7.6496
每股收益(LYR):-5.6333
淨資產收益率:-36.51%
總資產收益率:-22.61%
市淨率:3.26
市盈率(LYR):-10.72

資料載入中...

2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]